On December 7, 219, Imexpharm organized the ImexMedical Forum 2019, providing a platform for medical professionals to address pressing issues in the diagnosis and treatment of Community-Acquired Pneumonia (CAP).
The seminar was chaired by Associate Professor Dr. Dinh Ngoc Sy, Vice President of the Vietnam General Medical Association and Director of the Vietnam Respiratory Society’s Research and Training Center. Distinguished guests included Associate Professor Dr. Tran Van Ngoc, President of the Ho Chi Minh City Respiratory Society and Vice President of the Vietnam Respiratory Society, along with Dr. Nguyen Van Thanh, also Vice President of the Vietnam Respiratory Society. Representing Imexpharm were Chairman of the Board, Mr. Nguyen Quoc Dinh, and Deputy General Director Mr. Le Van Nha Phuong. Most notably, over 200 doctors attended as honored guests of the event.
Community-Acquired Pneumonia (CAP) is a respiratory infection contracted in the community, caused by common bacteria or viruses. It affects both children and elderly individuals with weakened immune systems. To facilitate advanced solutions for the diagnosis and treatment of CAP, Imexpharm partnered with the Vietnam Respiratory Society to organize the 2019 Medical Forum in Ho Chi Minh City. The forum provided valuable insights and practical applications for healthcare professionals, supporting their expertise in treating patients and enhancing the capabilities of medical staff across hospitals nationwide.
At the seminar, Dr. Tran Van Thanh delivered a presentation on Community-Acquired Pneumonia: Issues Needing Consensus in Clinical Practice. Assoc. Professor Dr. Tran Van Ngoc followed with a discussion on Community-Acquired Pneumonia and Healthcare-Associated Pneumonia: How to Handle in Practice?. These were the two main topics of the event.
In addition to knowledge updates, attendees had the opportunity to openly discuss and gain deeper insights into challenges related to pneumonia frequently encountered at local healthcare facilities. Experienced doctors and leading respiratory experts collaboratively addressed these issues, proposing superior solutions for preventing and treating CAP tailored to local conditions. This ensures patients benefit from enhanced medical care.
The success of the ImexMedical Forum 2019 in Ho Chi Minh City was the result of the dedication of the Vietnam Respiratory Society, expert speakers, and guests, with the steadfast support of Imexpharm. Together, they created a meaningful and practical initiative for Vietnam’s healthcare system.